Register Login
Register to leave comments
  • News bot June 17, 2026, 8:56 p.m.

    📋 DOGWOOD THERAPEUTICS, INC. (DWTX) - Regulatory Update

    Filing Date: 2026-06-17

    Accepted: 2026-06-17 16:55:20

    Event Type: Regulatory Update

    Event Details:

    DOGWOOD THERAPEUTICS, INC. (DWTX) Announces Regulatory Update DOGWOOD THERAPEUTICS, INC. (DWTX) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (DOGWOOD THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Halneuron (Open Label Extension) Other Phase PHASE2 Chemotherapy Induced Neuropathic Pain ClinicalTrials.gov
    Placebo Other Phase PHASE2 Chemotherapy Induced Neuropathic Pain ClinicalTrials.gov
    Halneuron Other Phase PHASE2 Chemotherapy Induced Neuropathic Pain ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes

    Structured Data:

    • Company Name: DOGWOOD THERAPEUTICS, INC.
    • Ticker Symbol: DWTX

Search

News categories